QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core (vol 26, pg 5399, 2016) 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 卷号: 30, 期号: 4, 页码: 1 作者:  Han, Mei;  Wang, Chengyan;  Ji, Yinchun;  Song, Zilan;  Xing, Li 收藏  |  浏览/下载：7/0  |  提交时间：2020/07/01 Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 卷号: 26, 期号: 22, 页码: 5399-5402 作者:   收藏  |  浏览/下载：66/0  |  提交时间：2019/01/08 EML4-ALK kinase  Oxidative metabolism  Benzo[b]carbazolone  hERG  Antitumor activity   An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 118, 页码: 244-249 作者:  Song, Zilan;  Xia, Zongjun;  Ji, Yinchun;  Xing, Li;  Gao, Yinglei 收藏  |  浏览/下载：70/0  |  提交时间：2019/01/08 Benzo[b]carbazolones  ALK inhibitors  RET kinase  Antiresistance  Non-small-cell lung cancer  Preclinical study   Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure-activity relationship study 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 卷号: 105, 页码: 39-56 作者:  Jiang, Xiaolong;  Zhou, Ji;  Ai, Jing;  Song, Zilan;  Peng, Xia 收藏  |  浏览/下载：61/0  |  提交时间：2019/01/08 Benzo[b]carbazolones  ALK inhibitors  Anti-cancer  Anti-resistance  Non-small-cell lung cancer